These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7023798)

  • 1. Chemotherapy in the management of stage III/IV grade 1 non-Hodgkin's lymphomas (Report no 17).
    Hayhoe FG
    Clin Radiol; 1981 Sep; 32(5):547-52. PubMed ID: 7023798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of cytostatic polychemotherapy in non-Hodgkin lymphomas].
    Kratzer H; Hehenwarter W; Denz H; Bliem J; Tschurtschenthaler G; Nitsche D; Huber H; Michlmayr G
    Wien Klin Wochenschr; 1983 Aug; 95(16):558-62. PubMed ID: 6689099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of generalised grade 2 non-Hodgkin's lymphomas (Report no 18).
    Pettingale KW
    Clin Radiol; 1981 Sep; 32(5):553-6. PubMed ID: 7273650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localised grade 2 non-Hodgkin's lymphoma: results of treatment with radiotherapy (BNLI Report No. 24).
    Lamb DS; Hudson GV; Easterling MJ; MacLennan KA; Jelliffe AM
    Clin Radiol; 1984 Jul; 35(4):253-60. PubMed ID: 6547377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.
    Lister TA; Cullen MH; Beard ME; Brearley RL; Whitehouse JM; Wrigley PF; Stansfeld AG; Sutcliffe SB; Malpas JS; Crowther D
    Br Med J; 1978 Mar; 1(6112):533-7. PubMed ID: 630211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors.
    Steward WP; Crowther D; McWilliam LJ; Jones JM; Deakin DP; Todd ID; Blackledge G; Wagstaff J; Scarffe JH; Harris M
    Cancer; 1988 Feb; 61(3):441-7. PubMed ID: 3338014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy in the treatment of localised non-Hodgkin's lymphoma (Report no 16).
    Phillips DL
    Clin Radiol; 1981 Sep; 32(5):543-6. PubMed ID: 7273649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
    Schmidt CG
    Strahlentherapie; 1977 May; 153(5):283-92. PubMed ID: 69343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden.
    Cavallin-Ståhl E; Möller TR
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):19-22. PubMed ID: 3952518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
    Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
    Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of prednimustine in treating non Hodgkin's lymphomas of favourable histological type.
    Klener P; Háber J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):103-8. PubMed ID: 2581855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation.
    Hoppe RT; Kushlan P; Kaplan HS; Rosenberg SA; Brown BW
    Blood; 1981 Sep; 58(3):592-8. PubMed ID: 7259838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent combination chemotherapy with chlorambucil and prednisone of low-grade malignant non-Hodgkin's lymphomas according to the Kiel classification.
    Stolzenbach G; Garbrecht M
    J Cancer Res Clin Oncol; 1979 Feb; 93(2):189-94. PubMed ID: 438282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
    Goldman JM
    Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
    Nissen NI; Pajak T; Glidewell O; Blom H; Flaherty M; Hayes D; McIntyre R; Holland JF
    Cancer Treat Rep; 1977 Sep; 61(6):1097-107. PubMed ID: 71208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.